Asami Takeda

2.2k total citations
137 papers, 1.2k citations indexed

About

Asami Takeda is a scholar working on Transplantation, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Asami Takeda has authored 137 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Transplantation, 60 papers in Nephrology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Asami Takeda's work include Renal Transplantation Outcomes and Treatments (60 papers), Renal Diseases and Glomerulopathies (44 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Asami Takeda is often cited by papers focused on Renal Transplantation Outcomes and Treatments (60 papers), Renal Diseases and Glomerulopathies (44 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Asami Takeda collaborates with scholars based in Japan, United States and Greece. Asami Takeda's co-authors include Kazuharu Uchida, Yoshihiko Watarai, Kunio Morozumi, Norihiko Goto, K Morozumi, Takaaki Kobayashi, Takahisa Hiramitsu, Shunji Narumi, Akio Katayama and Makoto Tsujita and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Kidney International.

In The Last Decade

Asami Takeda

131 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asami Takeda Japan 20 601 382 328 196 192 137 1.2k
Arnold M. Chonko United States 15 106 0.2× 699 1.8× 112 0.3× 332 1.7× 123 0.6× 28 1.3k
Murat Akyol Türkiye 19 183 0.3× 57 0.1× 630 1.9× 356 1.8× 90 0.5× 87 1.7k
Jason R. Wellen United States 20 446 0.7× 52 0.1× 778 2.4× 156 0.8× 69 0.4× 60 1.3k
Dong-Wook Kim South Korea 18 131 0.2× 70 0.2× 133 0.4× 73 0.4× 167 0.9× 84 1.3k
Joseph Weisstuch United States 7 63 0.1× 577 1.5× 74 0.2× 319 1.6× 313 1.6× 8 1.3k
José Ramón González‐Porras Spain 25 37 0.1× 96 0.3× 370 1.1× 183 0.9× 154 0.8× 102 1.8k
Catherine Lambert Belgium 20 29 0.0× 77 0.2× 364 1.1× 115 0.6× 98 0.5× 98 1.8k
Takashi Kaneko Japan 18 39 0.1× 18 0.0× 296 0.9× 207 1.1× 108 0.6× 80 1.1k
M. Nicholson United Kingdom 7 71 0.1× 44 0.1× 157 0.5× 400 2.0× 24 0.1× 10 873
Hani Oweira Germany 16 49 0.1× 14 0.0× 304 0.9× 241 1.2× 75 0.4× 63 947

Countries citing papers authored by Asami Takeda

Since Specialization
Citations

This map shows the geographic impact of Asami Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asami Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asami Takeda more than expected).

Fields of papers citing papers by Asami Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asami Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asami Takeda. The network helps show where Asami Takeda may publish in the future.

Co-authorship network of co-authors of Asami Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Asami Takeda. A scholar is included among the top collaborators of Asami Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asami Takeda. Asami Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miwa, Yuko, Kenta Iwasaki, Kenta Murotani, et al.. (2024). C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. Transplant International. 37. 13407–13407. 1 indexed citations
2.
Hidaka, Yuji, et al.. (2024). Water intake, baseline biopsy, and graft function after living donor kidney transplantation. Scientific Reports. 14(1). 3715–3715. 1 indexed citations
3.
Hiramitsu, Takahisa, Yuki Hasegawa, Kenta Futamura, et al.. (2024). Impact of Age 70 years or Older on Donors for Living-Donor Kidney Transplantation. Kidney International Reports. 9(5). 1321–1332. 1 indexed citations
4.
Hori, Mayuko, Hiroshi Takahashi, Yoshiko Mori, et al.. (2024). Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis. American Journal of Nephrology. 55(3). 399–405. 8 indexed citations
5.
6.
Kobayashi, Azusa, Asami Takeda, Chiharu Ito, et al.. (2023). Light Chain Deposition Disease Recurrence in Renal Allograft after Long-Term Remission. ˜The œNephron journals/Nephron journals. 147(Suppl. 1). 96–100. 2 indexed citations
7.
Hiramitsu, Takahisa, Toshihide Tomosugi, Kenta Futamura, et al.. (2021). Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age. Kidney International Reports. 6(12). 3026–3034. 9 indexed citations
8.
Doi, Yohei, Makoto Tsujita, Takayuki Hamano, et al.. (2021). The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study. American Journal of Transplantation. 21(9). 3043–3054. 4 indexed citations
9.
Tsujita, Makoto, Yohei Doi, Yoshitsugu Obi, et al.. (2020). Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial. Journal of Bone and Mineral Research. 37(2). 303–311. 11 indexed citations
10.
Hidaka, Yuji, Satoshi Hamanoue, Kenji Okumura, et al.. (2020). HbA1c and Aortic Calcification Index as Noninvasive Predictors of Pre-Existing Histopathological Damages in Living Donor Kidney Transplantation. Journal of Clinical Medicine. 9(10). 3266–3266. 2 indexed citations
11.
Murata, Minako, Asami Takeda, Chiharu Ito, et al.. (2020). Study of Glomerulopathy in Donors after Kidney Transplantation. ˜The œNephron journals/Nephron journals. 144(Suppl. 1). 86–90. 3 indexed citations
12.
Hiramitsu, Takahisa, Toshihide Tomosugi, Kenta Futamura, et al.. (2019). Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors. Kidney International Reports. 5(1). 13–27. 10 indexed citations
13.
Yamamoto, Takayuki, Yoshihiko Watarai, Kyoko Futamura, et al.. (2017). Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report. Transplantation Proceedings. 49(1). 159–162. 8 indexed citations
14.
Tanaka, Akihito, Daijo Inaguma, Eri Ito, et al.. (2016). Association between Plaque Score of the Carotid Artery and the Severity of Sleep Apnea Syndrome in Patients with Chronic Kidney Disease. Cardiorenal Medicine. 6(2). 159–168. 8 indexed citations
15.
Harita, Yutaka, Kiyonobu Ishizuka, Noriko Sugawara, et al.. (2014). Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Pediatric Nephrology. 29(9). 1553–1560. 26 indexed citations
16.
Morozumi, Kunio, Asami Takeda, Yasuhiro Otsuka, et al.. (2014). Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease. Clinical and Experimental Nephrology. 19(3). 371–378. 5 indexed citations
17.
Watarai, Yoshihiko, Takayuki Yamamoto, Takahisa Hiramitsu, et al.. (2013). Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation. Kidney International. 85(2). 425–430. 34 indexed citations
18.
Takeda, Asami, Yasuhiro Ohtsuka, Norihiko Goto, et al.. (2011). A case of tacrolimus‐associated thrombotic microangiopathy after ABO‐blood‐type‐incompatible renal transplantation. Clinical Transplantation. 25(s23). 15–18. 7 indexed citations
19.
Takeda, Asami, K Morozumi, T Haba, et al.. (2001). Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts. Transplantation Proceedings. 33(7-8). 3379–3380. 6 indexed citations
20.
Yoshida, Atsuhiro, et al.. (1995). Systemic lupus erythematosus-like serological disorders and nephropathy after interferon-α therapy of chronic hepatitis C. 6(1). 47–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnold M. Chonko Breakdown of academic impact, for papers by Murat Akyol Breakdown of academic impact, for papers by Jason R. Wellen Breakdown of academic impact, for papers by Dong-Wook Kim Breakdown of academic impact, for papers by Joseph Weisstuch Breakdown of academic impact, for papers by José Ramón González‐Porras Breakdown of academic impact, for papers by Catherine Lambert Breakdown of academic impact, for papers by Takashi Kaneko Breakdown of academic impact, for papers by M. Nicholson Breakdown of academic impact, for papers by Hani Oweira
Rankless by CCL
2026